Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [257]
News [757]
Articles [23]
Editorials [1]
Conferences [79]
elearning [2]
The 2022 OncoAlert Colloquium Day 5: GI Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 5: GI Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 3: Lung Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 2: GU Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
30 Jan 2023
HER-Vaxx is safe and provides clinical benefit over standard of care chemo for...
Dr Tanuj Chawla and Dr Giovanni Selvaggi
HER-Vaxx is safe and provides clinical benefit over standard of care chemo for patients with HER2-overexpressing gastric cancer ( Dr Tanuj Chawla and Dr Giovanni Selvaggi )
25 Jan 2023
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows...
Dr Emma Searle - University of Manchester, Manchester, UK
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma ( Dr Emma Searle - University of Manchester, Manchester, UK )
12 Dec 2022
Redefining cancer research priorities in the emerging context of the COVID-19...
Prof Richard Sullivan - King's College London, London, UK
Redefining cancer research priorities in the emerging context of the COVID-19 pandemic ( Prof Richard Sullivan - King's College London, London, UK )
22 Nov 2022
Cervical cancer prevention and care indicators for women living with HIV in Sub...
Dr Maša Davidović - Swiss Tropical and Public Health Insititute, Allschwil...
Cervical cancer prevention and care indicators for women living with HIV in Sub-Saharan Africa: Delphi Method ( Dr Maša Davidović - Swiss Tropical and Public Health Insititute, Allschwil, Switzerland )
18 Nov 2022
Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival...
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival benefit in R/R multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )
12 Oct 2022
Prognostic model of all-cause mortality at 30 days in patients with cancer and...
Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA
Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19 ( Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA )
11 Sep 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation